Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
172 hedge funds and large institutions have $1.03B invested in Silk Road Medical, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 44 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
43% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 44
32% more capital invested
Capital invested by funds: $778M → $1.03B (+$251M)
17% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 41
12% more funds holding
Funds holding: 154 → 172 (+18)
6% less call options, than puts
Call options by funds: $5.23M | Put options by funds: $5.56M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$41M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$32.8M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.2M |
| 4 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
+$16M |
| 5 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$13.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$89.2M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$44.6M |
| 3 |
Morgan Stanley
New York
|
-$31.6M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$21.8M |
| 5 |
TLP
Tri Locum Partners
New York
|
-$19.9M |
SILK Hedge Fund Activity: Q2 2024 in Review
172 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q2 2024, worth a combined $1.03B — up 32% from $778M a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new SILK positions and 44 closed out — a net gain of 19 holders — while 48 added to existing stakes and 41 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $41M. The largest seller was Wasatch Advisors, cutting an estimated $89.2M.
- 172 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q2 2024, up from 154 in Q1 2024.
- Funds reported $1.03B of Silk Road Medical, Inc. Common Stock stock for Q2 2024, up 32% quarter-over-quarter.
- 63 funds opened new Silk Road Medical, Inc. Common Stock positions in Q2 2024 and 44 closed out, a net change of +19 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q2 2024 was Magnetar Financial, an estimated $41M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q2 2024 was Wasatch Advisors, an estimated $89.2M sold.
Based on aggregated 13F filings for Q2 2024.